Open AccessGenetic Analysis of Pediatric Primary Adrenal Insufficiency of Unknown Etiology: 25 Years’ Experience in the UK
Author(s) -
Federica Buonocore,
Avinaash Maharaj,
Younus Qamar,
Katrin Koehler,
Jenifer P Suntharalingham,
Li Chan,
Bruno Ferraz-de-Souza,
Claire Hughes,
Lin Lin,
Rathi Prasad,
Jeremy Allgrove,
Edward Andrews,
Charles Buchanan,
Tim Cheetham,
Elizabeth Crowne,
Justin H. Davies,
John Welbourn Gregory,
Peter C. Hindmarsh,
Tony Hulse,
Nils Krone,
Pratik Shah,
M Guftar Shaikh,
Catherine Roberts,
Peter Clayton,
Mehul Dattani,
N. Simon Thomas,
Angela Huebner,
Adrian J. L. Clark,
Louise A. Metherell,
John C. Achermann
Publication year - 2021
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvab086
Subject(s) - etiology , genetic testing , medicine , adrenal insufficiency , congenital adrenal hyperplasia , primary adrenal insufficiency , pediatrics , genetic counseling , bioinformatics , genetics , biology
Context Although primary adrenal insufficiency (PAI) in children and young people is often due to congenital adrenal hyperplasia (CAH) or autoimmunity, other genetic causes occur. The relative prevalence of these conditions is poorly understood. Objective We investigated genetic causes of PAI in children and young people over a 25 year period. Design, Setting and Participants Unpublished and published data were reviewed for 155 young people in the United Kingdom who underwent genetic analysis for PAI of unknown etiology in three major research centers between 1993 and 2018. We pre-excluded those with CAH, autoimmune, or metabolic causes. We obtained additional data from NR0B1 (DAX-1) clinical testing centers. Intervention and Outcome Measurements Genetic analysis involved a candidate gene approach (1993 onward) or next generation sequencing (NGS; targeted panels, exomes) (2013-2018). Results A genetic diagnosis was reached in 103/155 (66.5%) individuals. In 5 children the adrenal insufficiency resolved and no genetic cause was found. Pathogenic variants occurred in 11 genes: MC2R (adrenocorticotropin receptor; 30/155, 19.4%), NR0B1 (DAX-1; 7.7%), CYP11A1 (7.7%), AAAS (7.1%), NNT (6.5%), MRAP (4.5%), TXNRD2 (4.5%), STAR (3.9%), SAMD9 (3.2%), CDKN1C (1.3%), and NR5A1 /steroidogenic factor-1 (SF-1; 0.6%). Additionally, 51 boys had NR0B1 variants identified through clinical testing. Although age at presentation, treatment, ancestral background, and birthweight can provide diagnostic clues, genetic testing was often needed to define the cause. Conclusions PAI in children and young people often has a genetic basis. Establishing the specific etiology can influence management of this lifelong condition. NGS approaches improve the diagnostic yield when many potential candidate genes are involved.